Related Experiment Video

Updated: Jul 8, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Evolving strategies in the management of aspergillosis

Shelley S Magill1, Tom M Chiller, David W Warnock

  • 1Centers for Disease Control and Prevention, Mycotic Diseases Branch, Division of Foodborne, Bacterial and Mycotic Diseases, 1600 Clifton Road, Mailstop C-09, Atlanta, GA 30333, USA. Smagill@cdc.gov

Expert Opinion on Pharmacotherapy
|January 19, 2008
PubMed

Insights

Invasive aspergillosis is a deadly fungal infection in immunocompromised patients. This review covers current and developing treatments, including surgical, immune, and prophylactic strategies for high-risk individuals.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Hematology

Background:

  • Aspergillus species are the primary cause of invasive mold infections.
  • These infections predominantly affect patients with hematologic malignancies and transplant recipients.
  • Despite treatment advances, invasive aspergillosis remains a significant cause of mortality.

Purpose of the Study:

  • To review current treatment strategies for invasive aspergillosis in adults.
  • To discuss surgical and immune-based therapeutic approaches.
  • To highlight recent developments in prophylaxis for at-risk populations.

Main Methods:

  • Literature review of current treatment and prophylaxis strategies.
  • Analysis of surgical interventions and immune-based therapies.
  • Examination of prophylactic measures in high-risk patient groups.

Main Results:

  • Invasive aspergillosis necessitates multifaceted treatment approaches.
  • Surgical and immune-based strategies play crucial roles in management.
  • Prophylaxis is essential for preventing infections in vulnerable patients.

Conclusions:

  • Effective management of invasive aspergillosis requires a comprehensive strategy.
  • Ongoing research is vital for improving outcomes in high-risk patients.
  • Advances in prophylaxis and treatment offer hope for reducing mortality.

More Related Videos

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation